Arginine vasopressin 1a receptor RS3 promoter microsatellites in schizophrenia: A study of the effect of the "risk" allele on clinical symptoms and facial affect recognition

Psychiatry Research

Volumn 225, Issue 3, 2015, Pages 739-740

  Golimbet, Vera ^a   Alfimova, Margarita ^a   Abramova, Lilia ^a   Kaleda, Vasily ^a   Gritsenko, Inga ^b  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

AVPR1A; PANSS; Psychosis

Indexed keywords

ARGININE VASOPRESSIN 1A RECEPTOR; ARGIPRESSIN RECEPTOR; UNCLASSIFIED DRUG; AVPR1A PROTEIN, HUMAN; MICROSATELLITE DNA; VASOPRESSIN RECEPTOR;

ADULT; ALLELE; ARTICLE; AUTISM; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FACIAL AFFECT RECOGNITION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NEGATIVE SYNDROME; ONSET AGE; PHENOTYPE; RECOGNITION; SCHIZOPHRENIA; SOCIAL BEHAVIOR; EMOTION; FACIAL EXPRESSION; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PERCEPTION; PHYSIOLOGY; PROMOTER REGION; RISK;

ADULT; ALLELES; AUTISTIC DISORDER; EMOTIONS; FACIAL EXPRESSION; FEMALE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, VASOPRESSIN; RISK; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL PERCEPTION;

EID: 84922946397     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.11.043     Document Type: Article

References (12)

1. Alfimova M.V., Abramova L.I., Barhatova A.I., Yumatova P.E., Lyachenko G.L., Golimbet V.E. Facial affect recognition deficit as a marker of genetic vulnerability to schizophrenia. Spanish Journal of Psychology 2009, 12:46-55.
2. Avinun R., Israel S., Shalev I., Gritsenko I., Bornstein G., Ebstein R.P., Knafo A. AVPR1A variant associated with preschoolers' lower altruistic behavior. PLoS One 2011, 6:e25274. 10.1371/journal.pone.0025274.
3. Brambilla F., Bondiolotti G.P., Maggioni M., Sciascia A., Grillo W., Sanna F., Latina A., Picotti G.B. Vasopressin (DDAVP) therapy in chronic schizophrenia: effects on negative symptoms and memory. Neuropsychobiology 1989, 20:113-119.
4. DeRosse P., Lencz T., Siris S.G., Kane J.M., Malhotra A.K. The genetics of symptom-based phenotypes: towards a molecular classification of schizophrenia. Schizophrenia Bulletin 2008, 34:1047-1053.
5. Guastella A.J., Kenyon A.R., Alvares G.A., Carson D.S., Hickie I.B. Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans. Biological Psychiatry 2010, 67:1220-1222.
6. Kohler C.G., Walker J.B., Martin E.A., Healey K.M., Moberg P.J. Facial emotion perception in schizophrenia: a meta-analytic review. Schizophrenia Bulletin 2010, 36:1009-1019.
7. Meyer-Lindenberg A., Kolachana B., Gold B., Olsh A., Nicodemus K., Mattay V., Dean M., Weinberger D.R. Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Molecular Psychiatry 2009, 14:968-975.
8. Rietschel M., Mattheisen M., Degenhardt F., Mühleisen T.W., Kirsch P., Esslinger C., Herms S., Demontis D., Steffens M., Strohmaier J., Haenisch B., Breuer R., Czerski P.M., Giegling I, Strengman E., Schmael C., Mors O., Mortensen P.B., Hougaard D.M., Ørntoft T., Kapelski P., Priebe L., Basmanav F.F., Forstner A.J., Hoffman P., Meier S., Nikitopoulos J., Moebus S., Alexander M., Mössner R., Wichmann H., Schreiber S., Rivandeneira F., Hofman A., Uitterlinden A.G., Wienker T.F., Schumacher J., Hauser J., Maier W., Cantor R.M., Erk S., Schulze T.G., Craddock N., Owen M.J., O'Donovan M.C., Børglum A.D., Rujescu D., Walter H., Meyer-Lindenberg A., Nöthen N.M., Ophoff R.A., Cichon S. Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Molecular Psychiatry 2012, 17(9):906-917. Genetic Risk and Outcome in Psychosis (GROUP Investigators), SGENE-plus ConsortiumSGENE-plus Consortium.
9. Skuse D.H., Gallagher L. Dopaminergic-neuropeptide interactions in the social brain. Trends in Cognitive Sciences 2009, 13:27-35.
10. Tansey K.E., Hill M.J., Cochrane L.E., Gill M., Anney R.J., Gallagher L. Functionality of promoter microsatellites of arginine vasopressin receptor 1A (AVPR1A): implications for autism. Molecular Autism 2011, 2:3. 10.1186/2040-2392-2-3.
11. Walum H., Westberg L., Henningsson S., Neiderhiser J.M., Reiss D., Igl W., Ganiban J.M., Spotts E.L., Pedersen N.L., Eriksson E., Lichtenstein P. Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:14153-14156.
12. Zink C.F., Meyer-Lindenberg A. Human neuroimaging of oxytocin and vasopressin in social cognition. Hormones and Behavior 2012, 61:400-409.